# Abrdn Healthcare Investors (HQH): Mutual Fund Facts & Distributions > Markdown mirror of https://www.dividenddata.com/funds/hqh for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice. - Issuer: abrdn · Asset class: Equity - Strategy: Passive Index · Inception: 1987-04-23 Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability... ## Key Facts | Metric | Value | |---|---| | Price | $20.32 | | Expense Ratio | 1.11% | | Assets Under Management | $1.16B | | NAV | — | | Holdings Count | — | | Distribution Yield (TTM) | 12.16% | | Annual Distribution (TTM) | $2.47 /share | | Distribution Frequency | Quarterly | | 52-Week Range | $17.14 – $24.85 | | Beta | 0.75 | ## Latest Distribution - Amount: $0.6600 /share - Ex-date: 2026-08-24 - Pay date: 2026-09-30 ## Frequently Asked Questions ### What does HQH invest in? Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States. ### What is the expense ratio of HQH? Abrdn Healthcare Investors (HQH) charges an expense ratio of 1.11%. This is the annual fee deducted from fund assets to cover management and operations. ### How big is HQH? Abrdn Healthcare Investors (HQH) manages $1.16B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation. ### Is HQH actively managed or an index fund? HQH is a passive index fund. It tracks a published benchmark by holding the constituents in their published weights. Index funds typically charge low expense ratios (HQH's is 1.11%) because there's no security selection cost. ### When was HQH launched? Abrdn Healthcare Investors (HQH) launched in April 1987 and is managed by abrdn. ### How has HQH performed? HQH's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon. ### Does HQH pay a dividend? Abrdn Healthcare Investors (HQH) currently distributes little or no income. Trailing-twelve-month yield is 12.16%. Investors looking for income should consider income-focused alternatives. See the Peers tab. ### How often does HQH pay dividends? Abrdn Healthcare Investors pays dividends Quarterly. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page. ### What is HQH's dividend yield? HQH's trailing-twelve-month yield is 12.16%, calculated from the sum of dividends over the past year divided by the current price. ### When is HQH's next ex-dividend date? The most recently announced ex-dividend date for HQH was 2026-08-24. The next ex-date typically follows Quarterly; once announced it appears at the top of the dividend history table on this page. ### How much will HQH's expense ratio cost me over 30 years? On a $10,000 investment compounding at 7% gross return, a 1.11% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees. ### How does HQH charge its expense ratio? The expense ratio is deducted in tiny daily slices from HQH's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price. ### Why does HQH cost more than a fund like VOO? HQH is a passive index fund (current expense ratio 1.11%). Differences from broad-market ETFs like VOO usually come from index licensing fees, asset class (bond funds typically run cheaper than equity), or fund scale (smaller funds spread fixed operating costs across less AUM). ### Are there cheaper alternatives to HQH? The Lower-Fee Alternatives card above lists mutual funds following the same investment strategy as HQH (1.11%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want. ## More on Dividend Data - Overview (HTML): https://www.dividenddata.com/funds/hqh - Distribution history: https://www.dividenddata.com/funds/hqh/dividend - Holdings & diversification: https://www.dividenddata.com/funds/hqh/diversification - Fees & cheaper alternatives: https://www.dividenddata.com/funds/hqh/expenses - Peer comparison: https://www.dividenddata.com/funds/hqh/peers Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.